News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Lilly’s RA drug Olumiant gains first approval in Europe Oral treatment could take the lead among next generation RA drugs
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
